The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The effect of statin use on survival outcomes in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with androgen receptor targeted therapies (ART).
 
George Slade Mellgard
No Relationships to Disclose
 
Nathaniel Saffran
No Relationships to Disclose
 
Zakaria Chakrani
No Relationships to Disclose
 
Stephen Mccroskery
No Relationships to Disclose
 
Nicole Taylor
No Relationships to Disclose
 
Bobby Chi-Hung Liaw
Consulting or Advisory Role - Bristol Myers Squibb; Bristol Myers Squibb; Daiichi Sankyo; Eisai; EMD Serono; Epizyme; Exelixis; Janssen Biotech; Myovant Sciences
Research Funding - Bayer; Sanofi
 
Matt D. Galsky
Stock and Other Ownership Interests - Rappta Therapeutics
Consulting or Advisory Role - Aileron Therapeutics; Astellas Pharma; AstraZeneca; Basilea; BioMotiv; Bristol-Myers Squibb; Dendreon; Dracen; Dragonfly Therapeutics; EMD Serono; Genentech; Gilead Sciences; GlaxoSmithKline; Incyte; Infinity Pharmaceuticals; Inovio Pharmaceuticals; Janssen; Lilly; Merck; Novartis; NuMab; Pfizer; Seagen; Silverback Therapeutics; Urogen pharma
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Genentech/Roche (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - METHODS AND COMPOSITIONS FOR TREATING CANCER AND RELATED METHODS. MOUNT SINAI SCHOOL OF MEDICINE July 2012 Application number: 20120322792
 
Kai Tsao
Consulting or Advisory Role - Bristol-Myers Squibb/Sanofi; Eisai; Exelixis
Research Funding - Exelixis; Exelixis
 
Vaibhav G. Patel
Employment - Arvinas
Stock and Other Ownership Interests - Arvinas; Bellicum Pharmaceuticals; crispr therapeutics; Editas Medicine; Finch Therapeutics
Consulting or Advisory Role - Sanofi; Seagen